Results 201 to 210 of about 539,723 (262)

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

Aerosol-Generating Potential of Topical Nasal Preparation Before Nasoendoscopy: A Quantitative Study. [PDF]

open access: yesLaryngoscope Investig Otolaryngol
Chua AJ   +7 more
europepmc   +1 more source

Acute Cytokine Responses to High-Intensity Intermittent Exercise in Humans: A Systematic Review. [PDF]

open access: yesInt J Mol Sci
Trybulski R   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy